Join
Live feed
·
INSIDERFilingvia Quantisnow
Coherus Oncology Inc. logo

Chief Commercial Officer Reider Paul covered exercise/tax liability with 4,858 shares, decreasing direct ownership by 6% to 82,069 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CHRS· Coherus Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CHRS (Coherus Oncology Inc.) and more on Quantisnow.